Outlook Therapeutics shares owned by Altium Capital Management
Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Altium Capital Management
from 13F filings
Historical chart of Altium Capital Management investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Altium Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $3.7M | 502k | 7.38 |